SCHEMBL15445258

SCHEMBL15445258

COc1cc2c(Nc3ccc(F)cc3Br)ncnc2cc1OCCn1ccnn1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 17/20 0.80
FGFR1 P11362 13/20 0.80
FLT1 P17948 13/20 0.80
EGFR P00533 10/20 0.80
FLT4 P35916 9/20 0.80
FGFR2 P21802 4/20 0.80
FGFR4 P22455 4/20 0.80
FGFR3 P22607 4/20 0.80
PDGFRB P09619 1/20 0.80
EPHA2 P29317 1/20 0.53
EPHB4 P54760 1/20 0.53
RET P07949 1/20 0.53
KIF5B P33176 1/20 0.53
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zd-4190 Free Base SCHEMBL173259 0.89 KDR (1.00) KDRFGFR1FLT1EGFRFLT4
SCHEMBL14040728 0.89 KDR (1.00) KDRFGFR1FLT1EGFRFLT4
Zd-4190 Free Base SCHEMBL29729304 0.89 KDR (1.00) KDRFGFR1FLT1EGFRFLT4
Zd-4190 Free Base SCHEMBL29363192 0.88 KDR (0.98) KDRFGFR1FLT1EGFRFLT4
SCHEMBL15445277 0.78 EGFR (0.80) KDRFGFR1FLT1EGFRFLT4
SCHEMBL5177296 0.77 KDR (0.79) KDRFGFR1FLT1EGFRFLT4
SCHEMBL5864534 0.75 KDR (0.77) KDRFGFR1FLT1EGFRFLT4
SCHEMBL17520360 0.74 KDR (0.83) KDRFGFR1FLT1EGFRFLT4
SCHEMBL5493929 0.74 ENPP1 (0.64) KDRFGFR1FLT1EGFRFLT4
SCHEMBL7459925 0.74 KDR (0.82) KDRFGFR1FLT1EGFRFLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140032198-A1 APPLICATION OF MULTIDIMENSIONAL MATRIX FOR DRUG MOLECULAS DESIGN AND THE METHODOLOGIES FOR DRUG MOLECULAR DESIGN YAN JINGBO (CN) 2014-01-30 US disclosed
US-20140032198-A1 APPLICATION OF MULTIDIMENSIONAL MATRIX FOR DRUG MOLECULAS DESIGN AND THE METHODOLOGIES FOR DRUG MOLECULAR DESIGN YAN JINGBO (CN) 2014-01-30 US disclosed